Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

Palma, If you read the study, the difference between the cancer and non cancer group using DR70 was insignificant. This was preliminary data from the study but it clearly shows that DR-70 does not produce anything medically worthwhile.

This is very typical of DR70 testing. The false positives are so high that it makes testing worthless.

Now, you can easily conclude why no doctors in the western world have any interest in DR70 / Onko Sure. It is essentially worthless.


"Results: The study group consisted of 26 women and 12 men, with a mean age of 52±11. There were no
differerence according demographics, between groups. Although Dr-70 reached a higher mean level in
the cancer group (0.47±0.27 microg/mL vs. 0.60±0.38 microg/mL), this difference was insignificant
(p>0.05)."